DrugPatentWatch Database Preview
Sun Pharm Inds Company Profile
What is the competitive landscape for SUN PHARM INDS, and when can generic versions of SUN PHARM INDS drugs launch?
SUN PHARM INDS has two hundred and twenty-nine approved drugs.
There are fourteen US patents protecting SUN PHARM INDS drugs. There are four tentative approvals on SUN PHARM INDS drugs.
Summary for Sun Pharm Inds
| US Patents: | 14 |
| Tradenames: | 168 |
| Ingredients: | 157 |
| NDAs: | 229 |
Drugs and US Patents for Sun Pharm Inds
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 076421-001 | Mar 28, 2003 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 200794-001 | May 2, 2012 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | RX | No | No | 5,908,838 | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Inc | MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | TABLET;ORAL | 040446-002 | Aug 8, 2002 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Inc | BETHANECHOL CHLORIDE | bethanechol chloride | TABLET;ORAL | 040897-003 | Apr 22, 2009 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Sun Pharm Inds
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | CREAM;TOPICAL | 019967-001 | Dec 27, 1990 | 4,619,921 | ➤ Sign Up |
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | OINTMENT;TOPICAL | 019968-001 | Dec 17, 1990 | 4,619,921 | ➤ Sign Up |
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Sun Pharm Inds Inc | LAC-HYDRIN | ammonium lactate | LOTION;TOPICAL | 019155-001 | Apr 24, 1985 | 4,105,783 | ➤ Sign Up |
| Sun Pharm Inds Inc | BACTRIM | sulfamethoxazole; trimethoprim | INJECTABLE;INJECTION | 018374-001 | Approved Prior to Jan 1, 1982 | RE28636 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM INDS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
| ➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
| ➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
Non-Orange Book US Patents for Sun Pharm Inds
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,559,187 | Liquid formulation of metformin | ➤ Sign Up |
| 9,192,615 | Method for the treatment of acne and certain dosage forms thereof | ➤ Sign Up |
| 8,722,650 | Extended-release minocycline dosage forms | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Sun Pharm Inds Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 104254319 | ➤ Sign Up |
| Japan | 2004505913 | ➤ Sign Up |
| Brazil | 0113102 | ➤ Sign Up |
| Austria | 270544 | ➤ Sign Up |
| Slovakia | 2102003 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2014000088 | Germany | ➤ Sign Up | PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT ATORVASTATIN ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON, INSBESONDERE ATORVASTATIN ALS ATORVASTATINCALCIUMTRIHYDRAT; NAT. REGISTRATION NO/DATE: 90223.00.00 20141113; FIRST REGISTRATION: FRANKREICH CIS: 6 928 917 6 20140912 |
| C0002 | Belgium | ➤ Sign Up | PRODUCT NAME: REPAGLINIDE; REGISTRATION NO/DATE: EU/1/98/076/001 19980817 |
| C0033 | France | ➤ Sign Up | PRODUCT NAME: ALISKIRENE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE E CELUI-CI, AMLODIPINE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, ET HYDROCHLOROTHIAZIDE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; NAT. REGISTRATION NO/DATE: EU/1/11/730/001 20111122; FIRST REGISTRATION: 6167801 20110705 |
| C/GB96/056 | United Kingdom | ➤ Sign Up | PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604 |
| C0025 | Belgium | ➤ Sign Up | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
